News

Investor Advisory: Lead Plaintiff Deadline Approaching for Dow Inc.

Investor Advisory: Lead Plaintiff Deadline Approaching for Dow Inc.

Investor Advisory on Class Action Against Dow Inc.

NEW YORK and NEW ORLEANS — Investors interested in Dow Inc. (NYSE: DOW) should take note of an important date as they may have legal recourse. Former Attorney General of Louisiana, Charles C. Foti, Jr., along with Kahn Swick & Foti, LLC (KSF), has brought to light the upcoming deadline for potential lead plaintiffs in a class action lawsuit against Dow.

Understanding the Legal Framework

If you acquired shares of Dow and experienced financial losses exceeding $100,000 within the specified timeframe, it is crucial to be aware that your right to recover could be at risk. The deadline to apply to serve as a lead plaintiff is set for October 28, 2025. This legal action pertains to securities purchased between January 30, 2025, and July 23, 2025.

Details of the Allegations

At the heart of this lawsuit are allegations that Dow and its executives failed to disclose significant information to investors, breaching federal securities regulations. Such omissions can severely impact investor confidence and market integrity, leading to substantial financial implications for shareholders.

Market Reactions to Dow's Financial Disclosure

The situation escalated on July 24, 2025, when Dow revealed a staggering non-GAAP loss per share of $0.42 for the second quarter of 2025, greatly surpassing analysts’ predictions of a loss in the range of $0.17 to $0.18. Additionally, Dow's net sales totaled $10.1 billion, marking a 7.3% decrease year-over-year, falling short of consensus estimates by $130 million. The company attributed these declines to a challenging earnings environment and uncertainties in trade and tariffs.

Consequences of the Disclosure

This dire financial announcement led to significant repercussions in the stock market. Following the news, shares of Dow plummeted by $5.30, equating to a notable 17.45% drop, with shares closing at $25.07. Such a decline reflects the sensitive nature of investor sentiments in reaction to corporate disclosures, especially when expectations are not met.

Moving Forward: Your Rights and Options

For investors looking to understand their rights further and how these developments can affect their investments, it is recommended to reach out to KSF Managing Partner Lewis Kahn. This consultation comes at no obligation and can provide valuable insights into the potential implications of the lawsuit.

About Kahn Swick & Foti, LLC

KSF, recognized as one of the leading boutique securities litigation firms in the nation, has a history of advocating on behalf of various clients facing corporate malfeasance. Their track record includes representing both institutional and retail investors seeking recoveries from investment losses caused by unethical corporate behavior. The firm boasts offices in several states, ensuring they can serve clients across the country effectively.

Getting in Touch

If you wish to learn more about your options regarding this class action or to inquire about serving as a lead plaintiff, Kahn Swick & Foti provides means for communication via phone or email. Engaging with them could be an essential step in safeguarding your economic interests in light of recent events surrounding Dow.

Frequently Asked Questions

What is the lead plaintiff deadline for the Dow class action?

The lead plaintiff application deadline is October 28, 2025.

What are the allegations against Dow Inc.?

Dow is accused of failing to disclose critical material information during the class period.

How did Dow's stock react to their financial disclosures?

Dow's shares fell sharply by 17.45% after the disappointing financial report.

Who can apply to be a lead plaintiff?

Investors who sustained losses over $100,000 during the specified class period may apply.

What should I do if I purchased Dow securities?

Contact KSF to discuss your legal rights and potential actions regarding the lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Brompton Funds Announces Upcoming Distribution for Investors

Updated Category News Views 190

Brompton Funds Announces Upcoming Distribution for Investors Toronto, an exciting hub for financial activity, is buzzing with news as Brompton Funds signals its intent to distribute to unitholders. In a recent announcement, the firm detailed its distribution plans for the Brompton Wellington Square AAA CLO ETF, set to be disbursed on June 13, 2025. Investors with a stake...

Continue Reading
Revolutionizing Consumer Experience with EPWK Curated Goods

Updated Category News Views 127

Transforming Daily Living: EPWK Curated Goods Launch EPWK, a pioneering force in creative design, has ignited a new trend with its innovative offering—"EPWK Curated Goods." In response to the repetitive nature of everyday life, this initiative is crafted to bring inspiration and aesthetic pleasure into the daily routines of consumers. The guiding philosophy behind this...

Continue Reading
Glucose Health, Inc. Leads the Way with Natural Formulations

Updated Category News Views 127

Glucose Health, Inc. Sets a New Standard In today's market, where health and wellness products are booming, Glucose Health, Inc. (OTC: GLUC) stands out as a beacon of innovation. The company has been redefining the standards of soluble fiber-powered drink mixes designed for metabolic wellness. Their flagship products, GlucoDown® and Fiber Up®, prove that healthy choices...

Continue Reading
Innovative AI Solutions by Green Grid Inc. to Combat Wildfires

Updated Category News Views 192

Green Grid Inc. Partners with Bear Valley Electric Service Green Grid Inc. (GGI) recently announced its exciting partnership with Bear Valley Electric Service (BVES) to utilize advanced AI technology to enhance grid monitoring and wildfire mitigation strategies. This collaboration represents a significant leap towards bolstering safety in areas susceptible to wildfires,...

Continue Reading
Georgia-Pacific Building Products Rejoins EIFS Industry Association

Updated Category News Views 151

Georgia-Pacific Building Products Rejoins EIFS Association The EIFS Industry Members Association (EIMA) has exciting news as it welcomes Georgia-Pacific Building Products back as an associate member. This decision highlights the commitment of Georgia-Pacific, a leading building materials manufacturer, to the advancement of Exterior Insulation and Finish Systems (EIFS)...

Continue Reading